We aimed to determine the optimum timing of midazolam administration prior
to propofol to achieve the maximal reduction in the dose of propofol requir
ed to induce anaesthesia. Female (ASA 1-2) patients, aged 18 to 45 years, w
eighing 40 to 75 kg and scheduled for gynaecological surgery were eligible
for the study. Consenting patients were randomly assigned to six groups. Gr
oup I received saline and Groups 2 to 6 received midazolam 3 mg at 1, 2, 4,
6 or 10 minutes respectively prior to propofol (n = 20 to 22 per group) in
a blinded manner Propofol was administered IV over 10 seconds and flushed
in with saline 5 ml. Two minutes later the patient's response to pressure a
pplied to the finger was determined as an index of loss of consciousness. T
he ED50 of propofol in each group was determined by the up-and-down method.
Propofol ED50 was reduced to 34 to 67% (P<0.001) in the midazolam treated
groups. There was no significant (P=0.14) difference in propofol ED50 among
the five groups which received midazolam. Patients who received midazolam
had less recollection of events surrounding induction (P<0.001) and recalle
d the induction experience as being more pleasant (P=0.03) than those who d
id not receive midazolam. These results indicate that midazolam may be give
n up to 10 minutes prior to propofol and still achieve a substantial dose r
eduction.